Literature DB >> 19201332

Class II Division 1 malocclusion with a high mandibular plane angle corrected with 2-phase treatment.

Masahiro Kurosawa1, Katsuya Ando, Shigemi Goto.   

Abstract

A 10-year-old girl with maxillary protrusion and crowding of the maxillary and mandibular anterior teeth was treated in 2 phases. In the first phase of treatment, maxillary anterior growth was restrained and mandibular anterior growth promoted for skeletal improvement. In the second phase, at age 13, 4 first premolars were extracted, and an edgewise appliance was used for alveolar improvement. Because the patient had a high mandibular plane angle with a large Frankfort-mandibular plane angle, special care was taken from the beginning to prevent mandibular clockwise rotation. The Frankfort-mandibular plane angle decreased 3.1 degrees at posttreatment. In addition to the skeletal changes, we obtained a favorable lateral profile. This was achieved by the alveolar changes from the lingual movement of the maxillary and mandibular anterior teeth, and the anterior growth of the nasal apex region. The occlusion was stable at the 38-month postretention follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19201332     DOI: 10.1016/j.ajodo.2006.09.059

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  2 in total

1.  Cranial base and maxillary changes in patients treated with Frankel' s functional regulator (1b).

Authors:  Juan-Jose Alió-Sanz; Carmen Iglesias-Conde; Jose Lorenzo-Pernía; Alejandro Iglesias-Linares; Asunción Mendoza-Mendoza; Enrique Solano-Reina
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-07-01

2.  Influence of Fixed Orthodontic Therapy on Pharyngeal Airway Dimensions after Correction of Class-I, -II and -III Skeletal Profiles in Adolescents.

Authors:  Yara Al Senani; Al Jouharah Al Shammery; Abeer Al Nafea; Nisreen Al Absi; Omar Al Kadhi; Deema Al-Shammery
Journal:  Int J Environ Res Public Health       Date:  2021-01-10       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.